Over the past three decades, Dr. Manikkam Suthanthiran and his colleagues at NewYork-Presbyterian/Weill Cornell is responsible for much of the progress in kidney transplantation.

NewYork-Presbyterian/Columbia, a Kidney Precision Medicine Project recruitment site, is working to understand the cell types that are specific to kidney injury and can be targeted with new therapeutic agents.